CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 120 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $65,000 | -64.1% | 24,371 | -41.6% | 0.00% | – |
| Q4 2021 | $181,000 | -14.2% | 41,761 | +0.9% | 0.00% | – |
| Q3 2021 | $211,000 | -14.9% | 41,408 | +5.6% | 0.00% | – |
| Q2 2021 | $248,000 | -46.3% | 39,199 | -34.5% | 0.00% | – |
| Q1 2021 | $462,000 | -28.5% | 59,820 | -39.4% | 0.00% | – |
| Q4 2020 | $646,000 | -55.9% | 98,661 | -55.2% | 0.00% | -100.0% |
| Q3 2020 | $1,464,000 | -30.1% | 220,132 | -12.5% | 0.00% | -50.0% |
| Q2 2020 | $2,095,000 | – | 251,475 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |